BDBM384874 2-(dimethylamino)-N-{(1R)-1-[3- fluoro-4- (trifluoromethoxy)phenyl]ethyl}-6- oxo-1,6-dihydropyrimidine-4- carboxamide::US10285989, Example 90

SMILES C[C@@H](NC(=O)c1cc(=O)[nH]c(n1)N(C)C)c1ccc(OC(F)(F)F)c(F)c1

InChI Key InChIKey=XCIRCBCEJKJZCK-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 384874   

TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM384874(2-(dimethylamino)-N-{(1R)-1-[3- fluoro-4- (trifluo...)
Affinity DataKi:  0.280nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent

TargetPhosphodiesterase(Rhesus macaque)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM384874(2-(dimethylamino)-N-{(1R)-1-[3- fluoro-4- (trifluo...)
Affinity DataKi:  0.690nMAssay Description:The activity of the compounds in accordance with the present invention as PDE2 inhibitors may be readily determined using a fluorescence polarization...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2020
Entry Details
US Patent